Seville – 28th June 2019

The Center for Industrial Technological Development (CDTI) once again supports a INFARMADE R&D project. In this case the titled “SPECIALTIES PHARMACEUTICALS AGAINST NEUROLOGICAL DISEASES CHRONICLES”.

The general objective of this project is the development of first generic pharmaceutical specialties of drugs from the group of immunosuppressants, based on the oral reference drug for the treatment and improvement of the evolution of certain diseases chronic neurological Likewise, the resulting medicines will have cheaper prices than those used as reference, which will allow both reduce costs to public health systems and increase the number of of patients who can access new state-of-the-art drugs.